02-373 C.M.R. ch. 21, § 2 - DEFINITIONS
1.
Abuse - A maladaptive pattern
of drug use that results in harm or places the individual at risk of harm.
Abuse of a prescription medication involves its use in a manner that deviates
from approved medical, legal, and social standards, generally to achieve a
euphoric state ("high") or to sustain opioid dependence, addiction, or that is
other than the purpose for which the medication was prescribed.
2.
Acute pain - The normal,
predicted physiological response to a noxious chemical, thermal or mechanical
stimulus and typically associated with invasive procedures, trauma and disease.
Acute pain is generally time limited, often lasting less than 90
days.
3.
Addiction - A
primary, chronic, neurobiologic disease, with genetic, psychosocial and
environmental factors influencing its development and manifestations. Addiction
is characterized by behaviors that include the following: impaired control over
drug use, craving, compulsive use and continued use despite harm. Physical
dependence and tolerance are normal physiological consequences of extended
opioid therapy for pain and are not the same as addiction.
4.
CDC - U.S. Department of
Health and Human Services Centers for Disease Control and Prevention.
5.
Chronic Pain - A state in
which pain persists beyond the usual course of an acute disease or healing of
an injury that may or may not be associated with an acute or chronic pathologic
process that causes continuous or intermittent pain for more than 90 days and
may last months or years.
6.
Clinician - An all opathic (MD) or osteopathic (DO) physician,
physician assistant (PA), advanced practice registered nurse (APRN), or
podiatrist (DPM).
7.
Controlled Substance - A drug that is subject to special
requirements under the federal Controlled Substances Act of 1970 (CSA), as
amended; see
21
U.S.C. §
801, et seq. Most opioid analgesics
are classified as Schedule II or III under the CSA, indicating that they have a
significant potential for abuse, a current acceptable medical use, and that
abuse of the drug may lead to severe psychological or physical
dependence.
8.
Drug
Diversion- The transfer of a controlled substance from authorized legal
and medically necessary use or possession to illegal and unauthorized use or
possession.
9.
Functional
Assessment- An objective review of an individual's ability to perform
key activities of daily living including mobility, self-care, ability to do
household chores, work and engage in social interactions. It is used to
establish or determine appropriate therapeutic interventions.
10.
Hospice Services - Is
defined in Title
22 M.R.S.,
section8621, subsection
11
and means a range of interdisciplinary services provided on a 24-hours-a-day,
7-days-a-week basis to a person who is terminally ill and that person's family.
Hospice services must be delivered in accordance with hospice philosophy.
11.
Medical Emergency
- Means an acute injury or illness that poses an immediate risk to a
person's life or long-term health.
12.
Misuse-All uses of a
prescription medication other than those that are directed by a clinician, used
by a patient within the law, and within the plan of treatment.
13.
Morphine Milligram Equivalent
(MME) - A conversion of various opioids to a morphine equivalent dose by
the use of accepted conversion tables.
14.
Opioid - Any compound that
binds to an opioid receptor in the central nervous system (CNS), including
naturally occurring, synthetic or semi-synthetic, and endogenous opioid
peptides.
15.
Opioid
Agonists - Drugs that bind to the opioid receptors and provide pain
relief. Examples include morphine, oxycodone, hydromorphone, fentanyl, codeine,
and hydrocodone. Buprenorphine is a partial agonist, meaning it activates the
opioid receptors in the brain, but to a much lesser degree than a true
opioid.
16.
Opioid
Antagonists - Drugs that cause no opioid effect and block full agonist
opioids such as morphine. Examples are naltrexone and naloxone. Naloxone is
sometimes used to reverse a heroin overdose.
17.
Opioid Use Disorder - See
Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM-5 criteria.
https://www.buppractice.com/node/1514.
18.
Pain - An unpleasant sensory
and emotional experience associated with actual or potential tissue damage or
described in terms of such damage.
19.
Palliative Care-Is defined
in Title
22
M.R.S., section1726, subsection
1,
paragraph A, and meanspatient-centered and family-focused medical care that
optimizes quality of life by anticipating, preventing and treating suffering
caused by a medical illness or a physical injury or condition that
substantially affects a patient's quality of life, including, but not limited
to, addressing physical, emotional, social and spiritual needs; facilitating
patient autonomy and choice of care; providing access to information;
discussing the patient's goals for treatment and treatment options, including,
when appropriate, hospice care; and managing pain and symptoms comprehensively.
Palliative care does not always include a requirement for hospice care or
attention to spiritual needs.
20.
Serious illness- Is defined in Title
22
M.R.S., section1726, subsection
1,
paragraph B, and means a medical illness or physical injury or condition that
substantially affects quality of life for more than a short period of time.
"Serious illness" includes, but is not limited to, Alzheimer's disease and
related dementias, lung disease, cancer, heart, renal or liver failure, and
chronic, unremitting or intractable pain such as neuropathic pain.
21.
Physical Dependence - A
state of adaptation manifested by drug class-specific signs and symptoms that
can be produced by abrupt cessation, rapid dose reduction, decreasing blood
level of the drug, and/or administration of an antagonist. Physical dependence,
by itself, does not equate with addiction.
22.
Substance Abuse - The use of
any substance(s) for non-therapeutic purposes or for purposes other than those
for which it is prescribed.
23.
Substance Misuse- The use of a medication (with therapeutic
intent) other than as directed or as indicated, and whether harm results or
not.
24.
Terminally
Ill - Is defined in Title
22 M.R.S.,
section8621, subsection
17
and means that a person has a limited life expectancy in the opinion of the
person's primary physician, physician assistant, advanced practice registered
nurse, or medical director.
25.
Tolerance -A state of physiologic adaptation in which exposure to
a drug induces changes that result in diminution of one or more of the drug's
effects over time. Tolerance is common in opioid treatment, has been
demonstrated following a single dose of opioids, and is not the same as
addiction.
26.
Universal
Precautions - A standardized approach to the assessment and on going
management of all pain patients who are prescribed controlled substances.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.